Literature DB >> 20211012

Two siblings with immunodeficiency, facial abnormalities and chromosomal instability without mutation in DNMT3B gene but liability towards malignancy; a new chromatin disorder delineation?

Anna Polityko1, Olga Khurs, Natalia Rumyantseva, Irina Naumchik, Nadezda Kosyakova, Holger Tönnies, Karl Sperling, Heidemarie Neitzel, Anja Weise, Thomas Liehr.   

Abstract

BACKGROUND: ICF syndrome (standing for Immunodeficiency, Centromere instability and Facial anomalies syndrome) is a very rare autosomal recessive immune disorder caused by mutations of the gene de novo DNA-methyltransferase 3B (DNMT3B). However, in the literature similar clinical cases without such mutations are reported, as well.
RESULTS: We report on a family in which the unrelated spouses had two female siblings sharing similar phenotypic features resembling ICF-syndrome, i.e. congenital abnormalities, immunodeficiency, developmental delay and high level of chromosomal instability, including high frequency of centromeric/pericentromeric rearrangements and breaks, chromosomal fragments despiralization or pulverization. However, mutations in DNMT3B could not be detected.
CONCLUSION: The discovery of a new so-called 'chromatin disorder' is suggested. Clinical, molecular genetic and cytogenetic characteristics are reported and compared to other 'chromatin disorders'.

Entities:  

Year:  2010        PMID: 20211012      PMCID: PMC2844377          DOI: 10.1186/1755-8166-3-5

Source DB:  PubMed          Journal:  Mol Cytogenet        ISSN: 1755-8166            Impact factor:   2.009


  8 in total

1.  ICF syndrome in a girl with DNA hypomethylation but without detectable DNMT3B mutation.

Authors:  Takeo Kubota; Hiroyasu Furuumi; Tomohiro Kamoda; Nobuaki Iwasaki; Naomi Tobita; Nobuko Fujiwara; Yu-Ichi Goto; Akira Matsui; Hiroyuki Sasaki; Tadashi Kajii
Journal:  Am J Med Genet A       Date:  2004-09-01       Impact factor: 2.802

2.  A routine method for the establishment of permanent growing lymphoblastoid cell lines.

Authors:  H Neitzel
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

3.  Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene.

Authors:  G L Xu; T H Bestor; D Bourc'his; C L Hsieh; N Tommerup; M Bugge; M Hulten; X Qu; J J Russo; E Viegas-Péquignot
Journal:  Nature       Date:  1999-11-11       Impact factor: 49.962

4.  A new and a reclassified ICF patient without mutations in DNMT3B and its interacting proteins SUMO-1 and UBC9.

Authors:  Barbara Kloeckener-Gruissem; David R Betts; Andreas Zankl; Wolfgang Berger; Tayfun Güngör
Journal:  Am J Med Genet A       Date:  2005-07-01       Impact factor: 2.802

5.  DNMT3B mutations and DNA methylation defect define two types of ICF syndrome.

Authors:  Y L Jiang; M Rigolet; D Bourc'his; F Nigon; I Bokesoy; J P Fryns; M Hultén; P Jonveaux; P Maraschio; A Mégarbané; A Moncla; E Viegas-Péquignot
Journal:  Hum Mutat       Date:  2005-01       Impact factor: 4.878

6.  Is 24-color FISH detection of in-vitro radiation-induced chromosomal aberrations suited to determine individual intrinsic radiosensitivity?

Authors:  Alma Kuechler; Susann Neubauer; Gerhard G Grabenbauer; Uwe Claussen; Thomas Liehr; Rolf Sauer; Thomas G Wendt
Journal:  Strahlenther Onkol       Date:  2002-04       Impact factor: 3.621

7.  Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant.

Authors:  R S Hansen; R Stöger; C Wijmenga; A M Stanek; T K Canfield; P Luo; M R Matarazzo; M D'Esposito; R Feil; G Gimelli; C M Weemaes; C D Laird; S M Gartler
Journal:  Hum Mol Genet       Date:  2000-11-01       Impact factor: 6.150

Review 8.  Human diseases with underlying defects in chromatin structure and modification.

Authors:  B Hendrich; W Bickmore
Journal:  Hum Mol Genet       Date:  2001-10-01       Impact factor: 6.150

  8 in total
  1 in total

1.  Long-term Culture of EBV-induced Human Lymphoblastoid Cell Lines Reveals Chromosomal Instability.

Authors:  Marianne Volleth; Martin Zenker; Ivana Joksic; Thomas Liehr
Journal:  J Histochem Cytochem       Date:  2020-02-28       Impact factor: 2.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.